Effects of Azithromycin on the Expression of ATP Binding Cassette Transporters in Epithelial Cells from the Airways of Cystic Fibrosis Patients

References

• I. Hurbain, Sermet-Gaudelus I, Vallee B et al. Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the DF508 mutation. Pediatr Res 2003; 54: 627–634.
   Google Scholar
• Lallemand JY, Stoven V. Induction by antitumoral drugs of proteins that functionally complement CFTR: a novel thera-py for cystic fibrosis? Lancet 1997; 350: 711–712.
   PubMed Web of Science ®Google Scholar
• Breuer W, Slotki IN, Ausiello DA, Cabantchik IZ. Induction of multidrug resistance downregulates the expression of CFTR in colon epithelial cells. Am J Physiol 1993; 265: C1711–C1715.
   PubMed Web of Science ®Google Scholar
• Trezise AE, Ratcliff R, Hawkins TE et al. Co-ordinate regulation of the cystic fibrosis and multidrug resistance genes in cystic fibrosis knockout mice. Hum Mol Genet 1997; 6: 527–537.
   Google Scholar
• Gill DR, Hyde SC, Higgins CF, Valverde MA, Mintenig GM, Sepulveda FV. Separation of drug transport and chloride channel functions of the human multidrug resistance P-glyco-protein. Cell 1992; 71: 23–32.
   PubMed Web of Science ®Google Scholar
• Valverde MA, Diaz M, Sepulveda FV, Gill DR, Hyde SC, Higgins CF. Volume-regulated chloride channels associat-ed with the human multidrug-resistance P-glycoprotein. Nature 1992; 355: 830–833.
   PubMed Web of Science ®Google Scholar
• Roman RM, Lomri N, Braunstein G et al. Evidence for multidrug resistance-1 P-glycoprotein-dependent regulation of cellular ATP permeability. J Membr Biol 2001; 183: 165–173.
   Google Scholar
• Braunstein GM, Roman RM, Clancy JP et al. Cystic fibrosis transmembrane conductance regulator facilitates ATP release by stimulating a separate ATP release channel for autocrine control of cell volume regulation. J Biol Chem 2001; 276: 6621–6630.
   Google Scholar
• Jaffe A, Francis J, Rosenthal M, Bush A. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 1998; 351: 420.
   PubMed Web of Science ®Google Scholar
• Equi A, Balfour-Lynn IM, Bush A, Rosenthal M. Long term azithromycin in children with cystic fibrosis: a ran-domised, placebo-controlled crossover trial. Lancet 2002; 360: 978–984.
   PubMed Web of Science ®Google Scholar
• Wolter J, Seeney S, Bell S, Bowler S, Masel P, McCormack J. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a ran-domised trial. Thorax 2002; 57: 212–216.
   PubMed Web of Science ®Google Scholar
• Pirzada OM, McGaw J, Taylor CJ, Everard M.I. Improved lung function and body mass index associated with long-term use of macrolide antibiotics. J Cyst Fibros 2003; 2: 69–71.
   PubMedGoogle Scholar
• Saiman L, Marshall BC, Mayer-Hamblett N et al. Azithromycin in patients with cystic fibrosis chronically infect-ed with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003; 290: 1749–1756.
   Google Scholar
• Hansen CR, Pressler T, Koch C, Hoiby N. Long-term azithromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study. J Cyst Fibros 2005; 4: 35–40.
   PubMedGoogle Scholar
• Altschuler EL. Azithromycin, the multidrug-resistant protein, and cystic fibrosis. Lancet 1998; 351: 1286.
   PubMed Web of Science ®Google Scholar
• Pradal U, Delmarco A, Morganti M, Cipolli M, Mini E, Cazzola G. Long-term azithromycin in cystic fibrosis: another possible mechanism of action? J Chemother 2005; 17: 393–400.
   PubMed Web of Science ®Google Scholar
• Cole SP, Bhardwaj G, Gerlach JH et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258 (5088): 1650–1654.
   Google Scholar
• Hainsworth AH, Henderson RM, Hickman ME et al. Hypotonicity-induced anion fluxes in cells expressing the mul-tidrug-resistance-associated protein, MRP. Eur J Physiol 1996; 432: 234–240.
   Google Scholar
• Gao L, Kim KJ, Yankaskas JR Forman HJ. Abnormal glutathione transport in cystic fibrosis airway epithelia. Am J Physiol Lung Cell Mol Physiol 1999; 277: L113–L118.
   PubMedGoogle Scholar
• Roum JH, Buhl R, McElvaney NG, Borok Z, Crystal RG. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol 1993; 75: 2419–2424.
   PubMed Web of Science ®Google Scholar
• Cho S, Urata Y, Ilada T et al. Glutathione downregu-lates the phosphorylation of I kappa B: autoloop regulation of the NF-kappa B-mediated expression of NF-kB subunits by TNF-alpha in mouse vascular endothelial cells. Biochem Biophys Res Commun 1998; 253: 104–108.
   Google Scholar
• Haddad JJ, Olver RE, Land SC. Antioxidant/pro-oxi-dant equilibrium regulates HIF-1 alpha and NF-kappa B redox sensitivity: evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J Biol Chem 2000; 275: 21130–21139.
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan A, Stecenko AA, King G et al. Exaggerated activation of nuclear factor-kappa B and altered Ikappa B-beta processing in cystic fibrosis bronchial epithelial cells. Am J of Respir Cell Mol Biol 2000; 23: 396–403.
   Google Scholar
• Egan M, Flotte TR, Afione S et al. Defective regulation of outwardly rectifying Cl channels by protein kinase A cor-rected by insertion of CFTR. Nature 1992; 358: 581–584.
   Google Scholar
• Zeitlin PL, Lu L, Rhim J et al. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am J Respir Cell Mol Biol 1991; 4: 313–319.
   Google Scholar
• Cozens AL, Yezzi MJ, Chin L et al. Characterization of immortal cystic fibrosis tracheobronchial gland epithelial cells. Proc Natl Acad Sci USA 1992; 89: 5171–5175.
   PubMed Web of Science ®Google Scholar
• Di Paolo A, Barbara C, Chella A, Angeletti CA, Del Tacca M. Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily. Pharmacol Res 2002; 46 (6): 545–550.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Center MS. Cloning and sequence analysis ofthe promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. Cancer Res 1994; 54: 4488–4492.
   PubMed Web of Science ®Google Scholar
• Nicolis E, Pasetto M, Cigana C, Pradal U, Assael BM, Melotti P. The GCC repeat length in the 5'UTR of MRP1 gene is polymorphic: a functional characterization of its rele-vance for cystic fibrosis. BMC Med Genet 2006; 7: 7. [Online]http://www.pubmedcentral.gov/articlerender.fcgi?tool =pubmed&pubmedid=16464259.
   Google Scholar
• Cigana C, Assael BM, Melotti P. Azithromycin selec-tively reduces tumor necrosis factor {alpha} in cystic fibrosis airway epithelial cells. Antimicrob Agents Chemother 2007; 51 (3): 975–81.
   PubMed Web of Science ®Google Scholar
• Cigana C, Nicolis E, Pasetto M, Assael BM, Melotti P. Anti-inflammatory effects of azithromycin in cystic fibrosis air- way epithelial cells. Biochem Biophys Res Commun 2006; 350 (4): 977–82.
   PubMed Web of Science ®Google Scholar
• Asgrimsson V, Gudjonsson T, Gudmundsson CH, Baldursson O. Novel effects of azithromycin on tight junction proteins in human airway epithelia. Antimicrob Agents Chemother 2006; 50: 1805–1812.
   PubMed Web of Science ®Google Scholar
• Wagner T, Soong G, Sokol S, Saiman L, Prince A. Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients. Chest 2005; 128 (2): 912–919.
   PubMed Web of Science ®Google Scholar
• Yamanaka Y, Tamari M, Nakahata T, Nakamura Y. Gene expression profiles of human small airway epithelial cells treated with low doses of 14- and 16-membered macrolides. Biochem Biophys Res Commun 2001; 287 (1): 198–203.
   PubMed Web of Science ®Google Scholar
• Barker PM, Gillie DJ, Schechter MS, Rubin BK. Effect of macrolides on in vivo ion transport across cystic fibrosis nasal epithelium. Am J Respir Crit Care Med 2005; 171: 868–871.
   PubMed Web of Science ®Google Scholar
• Equi AC, Davies JC, Painter H et al. Exploring the mechanisms of macrolides in cystic fibrosis. Respir Med 2006; 100: 687–697.
   Google Scholar
• Gant TW, O'Connor CK, Corbitt R, Thorgeirsson U, Thorgeirsson SS. In vivo induction of liver P-glycoprotein expression by xenobiotics in monkeys. Toxicol Appl Pharmacol 1995; 133: 269–276.
   PubMed Web of Science ®Google Scholar
• Ge N, Nakamura Y, Nakaya Y, Sone S. Interferon-gamma activates outwardly rectifying chloride channels in the human bronchial epithelial cell line BEAS-2B. J Med Invest 2001; 48: 97–101.
   PubMedGoogle Scholar
• Tagaya E, Tamaoki J, Kondo M, Nagai A. Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion. Chest 2002; 122: 213–218.
   PubMed Web of Science ®Google Scholar